Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9b442f17c57e6903e584b8486085ac9 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 |
filingDate |
1999-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2004-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d95953dd253d2e8024e7129fb46c771e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a279a97a025a6ec519a4cd9a848efc47 |
publicationDate |
2004-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6764674-B1 |
titleOfInvention |
Adenovirus E1B shuttle vectors |
abstract |
Provided are replication competent, recombinant adenovirus vectors containing mutations in the E1B region which permit the easy deletion of a gene or genes therein, and optionally the substitution therefore of a heterologous gene that substantially exhibits the temporal expression pattern of the E1b region gene(s) deleted. Such vectors have applications for the treatment of disease, and preferably for the treatment of neoplastic disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10047347-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10876097-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11618888-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015315547-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2509388-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10738283-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003219410-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2509388-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018113971-A |
priorityDate |
1999-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |